These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36418960)

  • 1. Using information from network meta-analyses to optimize the power and sample allocation of a subsequent trial with a new treatment.
    Hu D; Wang C; Ye F; O'Connor AM
    BMC Med Res Methodol; 2022 Nov; 22(1):299. PubMed ID: 36418960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel power prior approach for borrowing historical control data in clinical trials.
    Shi Y; Li W; Liu GF
    Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning a future randomized clinical trial based on a network of relevant past trials.
    Salanti G; Nikolakopoulou A; Sutton AJ; Reichenbach S; Trelle S; Naci H; Egger M
    Trials; 2018 Jul; 19(1):365. PubMed ID: 29996869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simulation study for comparing testing statistics in response-adaptive randomization.
    Gu X; Lee JJ
    BMC Med Res Methodol; 2010 Jun; 10():48. PubMed ID: 20525382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
    Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
    Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.
    Bennett M; White S; Best N; Mander A
    Pharm Stat; 2021 May; 20(3):462-484. PubMed ID: 33474798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inclusion of real world evidence in clinical development planning.
    Martina R; Jenkins D; Bujkiewicz S; Dequen P; Abrams K;
    Trials; 2018 Aug; 19(1):468. PubMed ID: 30157904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
    Li Z; Quartagno M; Böhringer S; van Geloven N
    Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach.
    Qi H; Rizopoulos D; van Rosmalen J
    Res Synth Methods; 2023 May; 14(3):396-413. PubMed ID: 36625478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
    Guo JH; Chen HJ; Luh WM
    Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trials.
    Zhang W; Pan Z; Yuan Y
    Contemp Clin Trials; 2021 Nov; 110():106559. PubMed ID: 34506959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connecting a disconnected trial network with a new trial: optimizing the estimation of a comparative effect in a network meta-analysis.
    McKeen L; Morris P; Wang C; Morris MD; O'Connor AM
    BMC Med Res Methodol; 2023 Apr; 23(1):79. PubMed ID: 37013490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design for a three-arm equivalence clinical trial with binomially distributed outcomes.
    Tseng YK; Hsu KN
    J Biopharm Stat; 2021 Nov; 31(6):736-744. PubMed ID: 34460350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
    Zhang W; Pan Z; Yuan Y
    J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastic priors to dynamically borrow information from historical data in clinical trials.
    Jiang L; Nie L; Yuan Y
    Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing two variances for superiority/non-inferiority and equivalence: Using the exhaustion algorithm for sample size allocation with cost.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2020 May; 73(2):316-332. PubMed ID: 31190402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.